1-6 of 6
Hans-Georg Rammensee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

Markus W. Löffler, Stefania Gori, Francesco Izzo, Andrea Mayer-Mokler, Paolo A. Ascierto, Alfred Königsrainer, Yuk Ting Ma, Bruno Sangro, Sven Francque, Luisa Vonghia, Alessandro Inno, Antonio Avallone, Jörg Ludwig, Diego Duarte Alcoba, Christian Flohr, Katrin Aslan, Regina Mendrzyk, Heiko Schuster, Marco Borrelli, Danila Valmori, Tanguy Chaumette, Regina Heidenreich, Cécile Gouttefangeas, Greta Forlani, Maria Tagliamonte, Caterina Fusco, Roberta Penta, Mercedes Iñarrairaegui, Ulrike Gnad-Vogt, Carsten Reinhardt, Toni Weinschenk, Roberto S. Accolla, Harpreet Singh-Jasuja, Hans-Georg Rammensee, Luigi Buonaguro
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (12): 2555–2566.
https://doi.org/10.1158/1078-0432.CCR-21-4424
Published: 13 June 2022
View article titled, Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Open the PDF for Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells

Yuko Yokoyama, Frank Grünebach, Susanne M. Schmidt, Annkristin Heine, Maik Häntschel, Stefan Stevanovic, Hans-Georg Rammensee, Peter Brossart
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5503–5511.
https://doi.org/10.1158/1078-0432.CCR-07-4041
Published: 02 September 2008
View article titled, <em>Matrilysin</em> (<em>MMP-7</em>) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells
Open the PDF for <em>Matrilysin</em> (<em>MMP-7</em>) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells in another window
Journal Articles

Identification and Characterization of T-Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen

Cristina N. Boß, Frank Grünebach, Katharina Brauer, Maik Häntschel, Valbona Mirakaj, Toni Weinschenk, Stefan Stevanovic, Hans-Georg Rammensee, Peter Brossart
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3347–3355.
https://doi.org/10.1158/1078-0432.CCR-06-2156
Published: 01 June 2007
View article titled, Identification and Characterization of T-Cell Epitopes Deduced from <em>RGS5</em>, a Novel Broadly Expressed Tumor Antigen
Open the PDF for Identification and Characterization of T-Cell Epitopes Deduced from <em>RGS5</em>, a Novel Broadly Expressed Tumor Antigen in another window
Journal Articles

Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1

Anne Marie Asemissen, Ulrich Keilholz, Stefan Tenzer, Margret Müller, Steffen Walter, Stefan Stevanovic, Hansjörg Schild, Anne Letsch, Eckhard Thiel, Hans-Georg Rammensee, Carmen Scheibenbogen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7476–7482.
https://doi.org/10.1158/1078-0432.CCR-06-1337
Published: 22 December 2006
View article titled, Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1
Open the PDF for Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1 in another window
Journal Articles

Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas

Jörn Dengjel, Maria-Dorothea Nastke, Cécile Gouttefangeas, Gitsios Gitsioudis, Oliver Schoor, Florian Altenberend, Margret Müller, Björn Krämer, Anna Missiou, Martina Sauter, Jörg Hennenlotter, Dorothee Wernet, Arnulf Stenzl, Hans-Georg Rammensee, Karin Klingel, Stefan Stevanović
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4163–4170.
https://doi.org/10.1158/1078-0432.CCR-05-2470
Published: 20 July 2006
View article titled, Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas
Open the PDF for Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas in another window
Includes: Supplementary data
Journal Articles

Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes

Kerstin Schag, Susanne M. Schmidt, Martin R. Müller, Toni Weinschenk, Silke Appel, Markus M. Weck, Frank Grünebach, Stefan Stevanovic, Hans-Georg Rammensee, Peter Brossart
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (11): 3658–3666.
https://doi.org/10.1158/1078-0432.CCR-03-0640
Published: 01 June 2004
View article titled, Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes
Open the PDF for Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes in another window